Regulatory and Legal Framework for Peptide Use The FDA's categorization of peptides and their legality will play a significant role in how physicians can discuss and prescribe them to patients, and if they are moved to a category one list, physicians may be able to have more open discussions with patients about their use 4m30s
Traina G, Bernardi R, Rizzo M, Calvani M, Durante M, Brunelli M
Targeting BIG3PHB2 interaction to overcome tamoxifen resistance in breast cancer cells
In one single-center trial of 72 subjects using a controlled-adverse-environment model, the T4 eye drop did not meet its co-primary endpoints (ocular discomfort and inferior corneal staining) at the primary time point, but it did produce statistically significant improvements on several secondary endpoints, including central and superior corneal staining, with no adverse events reported
"Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications." Current Neuropharmacology
BPC-157 shows particular promise for gastrointestinal healing